Case Report

Published on 29 Oct 2021

Toxic Epidermal Necrolysis-Like Reaction Following Combination Therapy With Camrelizumab and Apatinib for Advanced Gallbladder Carcinoma

in Cancer Immunity and Immunotherapy

Yonghao Yang
Jun Li
Brian G. Till
Jun Wang
Bicheng Zhang
Hanping Wang
Hao Huang
Tiepeng Li
Quanli Gao
Hongle Li

Frontiers in Oncology

doi 10.3389/fonc.2021.728253

4,309 views
2 citations

Review

Published on 28 Oct 2021

Recent Advances in the Mechanism Research and Clinical Treatment of Anti-Angiogenesis in Biliary Tract Cancer

in Cancer Immunity and Immunotherapy

Yue Wang
Tianli Chen
Kangshuai Li
Wentao Mu
Zengli Liu
Anda Shi
Jialiang Liu
Wei Zhao
Shuo Lian
Shaohui Huang

Frontiers in Oncology

doi 10.3389/fonc.2021.777617

3,754 views
8 citations

Mini Review

Published on 28 Oct 2021

Modification of EBV-Associated Pathologies and Immune Control by Coinfections

in Cancer Immunity and Immunotherapy

Christian Münz

Frontiers in Oncology

doi 10.3389/fonc.2021.756480

3,491 views
6 citations

Review

Published on 28 Oct 2021

Clinical Trials of the BTK Inhibitors Ibrutinib and Acalabrutinib in Human Diseases Beyond B Cell Malignancies

in Cancer Immunity and Immunotherapy

Sining Zhu
Jaeyong Jung
Eton Victor
Johann Arceo
Samantha Gokhale
Ping Xie

Frontiers in Oncology

doi 10.3389/fonc.2021.737943

10,878 views
21 citations

Original Research

Published on 27 Oct 2021

Integrin Alpha-2 as a Potential Prognostic and Predictive Biomarker for Patients With Lower-Grade Glioma

in Cancer Immunity and Immunotherapy

Li Lin
Kai Huang
Zewei Tu
Xingen Zhu
Jingying Li
Kunjian Lei
Min Luo
Peng Wang
Chuandong Gong
Xiaoyan Long

Frontiers in Oncology

doi 10.3389/fonc.2021.738651

4,354 views
5 citations

Review

Published on 26 Oct 2021

NK Cell-Based Immunotherapy and Therapeutic Perspective in Gliomas

in Cancer Immunity and Immunotherapy

Changqing Pan
You Zhai
Guanzhang Li
Tao Jiang
Wei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.751183

5,727 views
13 citations

Review

Published on 26 Oct 2021

The Role of the Immune Response in Brain Metastases: Novel Imaging Biomarkers for Immunotherapy

in Cancer Immunity and Immunotherapy

Rasheed Zakaria
Mark Radon
Samantha Mills
Drew Mitchell
Carlo Palmieri
Caroline Chung
Michael D. Jenkinson

Frontiers in Oncology

doi 10.3389/fonc.2021.711405

2,938 views
3 citations

Case Report

Published on 20 Oct 2021

Rapid Response to the Combination of Lenvatinib and Sintilimab in a Pancreatic Acinar Cell Carcinoma Patient With Elevated Alpha-Fetoprotein: A Case Report

in Cancer Immunity and Immunotherapy

Lanqun Qin
Jie Shen
Yueling Yang
Zhengyun Zou

Frontiers in Oncology

doi 10.3389/fonc.2021.692480

2,190 views
2 citations

Original Research

Published on 18 Oct 2021

Co-Occurrence of Myeloid and Lymphoid Neoplasms: Clinical Characterization and Impact on Outcome. A Single-Center Cohort Study

in Cancer Immunity and Immunotherapy

Cristina Bucelli
Bruno Fattizzo
Daniele Cattaneo
Juri Alessandro Giannotta
Kordelia Barbullushi
Raffaella Pasquale
Enrico Barozzi
Maria Chiara Barbanti
Loredana Pettine
Francesca Gaia Rossi

Frontiers in Oncology

doi 10.3389/fonc.2021.701604

2,883 views
3 citations

Case Report

Published on 15 Oct 2021

Case Report: Response to Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Recurrent Myxofibrosarcoma: A Report of 2 Cases

in Cancer Immunity and Immunotherapy

Edmund K. Bartlett
Sandra P. D’Angelo
Ciara M. Kelly
Robert H. Siegelbaum
Charles Fisher
Cristina R. Antonescu
Charlotte E. Ariyan

Frontiers in Oncology

doi 10.3389/fonc.2021.725484

1,684 views
7 citations

Original Research

Published on 15 Oct 2021

Transcriptomic Analysis Identified Two Subtypes of Brain Tumor Characterized by Distinct Immune Infiltration and Prognosis

in Cancer Immunity and Immunotherapy

Xilin Shen
Xiaoli Wang
Hongru Shen
Mengyao Feng
Dan Wu
Yichen Yang
Yang Li
Meng Yang
Wei Ji
Wei Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.734407

3,226 views
7 citations

Original Research

Published on 15 Oct 2021

Serum Anti-14-3-3 Zeta Autoantibody as a Biomarker for Predicting Hepatocarcinogenesis

in Cancer Immunity and Immunotherapy

Ting Wang
Xue-ying Huang
Su-jun Zheng
Ye-ying Liu
Si-si Chen
Feng Ren
Jun Lu
Zhong-ping Duan
Mei Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.733680

2,590 views
4 citations

Review

Published on 14 Oct 2021

Development and Characterization of a Novel Non-Lytic Cancer Immunotherapy Using a Recombinant Arenavirus Vector Platform

in Cancer Immunity and Immunotherapy

Henning Lauterbach
Sarah Schmidt
Kia Katchar
Xiaoping Qing
Corinne Iacobucci
Andy Hwang
Katia Schlienger
Ursula Berka
Josipa Raguz
Sarah Ahmadi-Erber

Frontiers in Oncology

doi 10.3389/fonc.2021.732166

7,812 views
12 citations

Review

Published on 14 Oct 2021

A Forgotten Corner in Cancer Immunotherapy: The Role of Lipids

in Cancer Immunity and Immunotherapy

Yang Yu
Lei Gao
Yunpeng Wang
Bo Xu
Ewetse Paul Maswikiti
Haiyuan Li
Peng Zheng
Pengxian Tao
Lin Xiang
Baohong Gu

Frontiers in Oncology

doi 10.3389/fonc.2021.751086

5,043 views
12 citations

Case Report

Published on 08 Oct 2021

Case Report: Anlotinib Reverses Nivolumab Resistance in Advanced Primary Pulmonary Lymphoepithelioma-Like Carcinoma With FGFR3 Gene Amplification

in Cancer Immunity and Immunotherapy

Yanyang Liu
Lang Long
Jiewei Liu
Lingling Zhu
Feng Luo

Frontiers in Oncology

doi 10.3389/fonc.2021.749682

3,505 views
8 citations

Correction

Published on 07 Oct 2021

Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis

in Cancer Immunity and Immunotherapy

Jun Meng
XiaoQin Wu
Zhen Sun
RenDe Xun
MengSi Liu
Rui Hu
JianChao Huang

Frontiers in Oncology

doi 10.3389/fonc.2021.768128

2,411 views

Navigation group

Articles

Toxic Epidermal Necrolysis-Like Reaction Following Combination Therapy With Camrelizumab and Apatinib for Advanced Gallbladder Carcinoma

Recent Advances in the Mechanism Research and Clinical Treatment of Anti-Angiogenesis in Biliary Tract Cancer

Modification of EBV-Associated Pathologies and Immune Control by Coinfections

Clinical Trials of the BTK Inhibitors Ibrutinib and Acalabrutinib in Human Diseases Beyond B Cell Malignancies

Integrin Alpha-2 as a Potential Prognostic and Predictive Biomarker for Patients With Lower-Grade Glioma

NK Cell-Based Immunotherapy and Therapeutic Perspective in Gliomas

The Role of the Immune Response in Brain Metastases: Novel Imaging Biomarkers for Immunotherapy

Rapid Response to the Combination of Lenvatinib and Sintilimab in a Pancreatic Acinar Cell Carcinoma Patient With Elevated Alpha-Fetoprotein: A Case Report

Co-Occurrence of Myeloid and Lymphoid Neoplasms: Clinical Characterization and Impact on Outcome. A Single-Center Cohort Study

Case Report: Response to Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Recurrent Myxofibrosarcoma: A Report of 2 Cases

Transcriptomic Analysis Identified Two Subtypes of Brain Tumor Characterized by Distinct Immune Infiltration and Prognosis

Serum Anti-14-3-3 Zeta Autoantibody as a Biomarker for Predicting Hepatocarcinogenesis

Development and Characterization of a Novel Non-Lytic Cancer Immunotherapy Using a Recombinant Arenavirus Vector Platform

A Forgotten Corner in Cancer Immunotherapy: The Role of Lipids

Case Report: Anlotinib Reverses Nivolumab Resistance in Advanced Primary Pulmonary Lymphoepithelioma-Like Carcinoma With FGFR3 Gene Amplification

Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis